iRhythm Holdings (IRTC) Shareholder's Equity Growth (1y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | iRhythm Holdings | 3.55 Bn | 3.00 Bn | 141.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 86.02% |
| Dec 31, 2025 | 68.02% |
| Sep 30, 2025 | 69.85% |
| Jun 30, 2025 | 4.51% |
| Mar 31, 2025 | -4.01% |
| Dec 31, 2024 | -56.73% |
| Sep 30, 2024 | -67.35% |
| Jun 30, 2024 | -55.70% |
| Mar 31, 2024 | -59.30% |
| Dec 31, 2023 | -12.39% |
| Sep 30, 2023 | -8.12% |
| Jun 30, 2023 | -8.49% |
| Mar 31, 2023 | -9.40% |
| Dec 31, 2022 | -14.20% |
| Sep 30, 2022 | -19.14% |
| Jun 30, 2022 | -20.17% |
| Mar 31, 2022 | -20.91% |
| Dec 31, 2021 | -18.18% |
| Sep 30, 2021 | -11.57% |
| Jun 30, 2021 | 159.82% |
| Mar 31, 2021 | 147.70% |
| Dec 31, 2020 | 152.28% |
| Sep 30, 2020 | 134.63% |
| Jun 30, 2020 | 152.28% |
| Mar 31, 2020 | 162.29% |
| Dec 31, 2019 | 159.72% |
| Sep 30, 2019 | 125.56% |
| Jun 30, 2019 | -30.42% |
| Mar 31, 2019 | -34.23% |
| Dec 31, 2018 | -34.29% |
| Sep 30, 2018 | -25.97% |
| Jun 30, 2018 | -23.14% |
| Mar 31, 2018 | -18.88% |
| Dec 31, 2017 | -14.72% |
| Sep 30, 2017 | 174.30% |
| Dec 31, 2016 | 191.55% |